Td Waterhouse Canada Inc. Bio N Tech Se Transaction History
Td Waterhouse Canada Inc.
- $14.8 Trillion
- Q2 2024
A detailed history of Td Waterhouse Canada Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 30 shares of BNTX stock, worth $3,323. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30
Previous 30
-0.0%
Holding current value
$3,323
Previous $3.72 Million
1.88%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BNTX
# of Institutions
325Shares Held
38.7MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.28MShares$917 Million0.53% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$531 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$485 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$324 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$210 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $26.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...